"The new treatment could eventually become an alternative to corneal transplantation," Dr Sayan Basu, Consultant Corneal Surgeon, LV Prasad Eye Institute, told reporters here.
The stromal stem cells were retrieved from the area between the white and black part of the eyeball called the limbus, he said.
"We found that when the stem cells were applied to damaged corneas they healed and became clear again within four weeks of treatment, while those untreated remained clouded," Basu said.
Basu, along with James L Funderburgh, a professor of ophthalmology at the University of Pittsburgh School of Medicine, US, tested the stem cells they obtained from human eyes on an experimental model of corneal scarring.
"Even at the microscopic level, we could not tell the difference between the tissues that were treated with stem cells and undamaged cornea," a release quoted Dr Funderburgh as saying.
The findings, published today in 'Science Translational Medicine' could one day restore vision for millions of people worldwide and decrease the need for corneal transplants, Basu said.
"The discovery also underwent the peer review process. In India, scarring is the main indication for corneal transplantation, for which 2,00000 people are currently estimated to be in the waiting lists," Basu added.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
